Conference Presentation, Panel, Fireside Chat
The 2014 Atlanta Summit - - The Economic Burden of Chronic Disease: Preventing the Preventable
- Heart disease prevalence is forecast to remain below baseline projections due to declining smoking rates and the impact of generic statins, while stroke prevalence is expected to be substantially higher than original assumptions.
- Cancer prevalence is predicted to be slightly above baseline depending on the specific type, whereas diabetes and hypertension prevalence are projected to be substantially above baseline levels, a trend driven by rising obesity and potential delays in population health initiatives.
- Undiagnosed type 2 diabetes cases are expected to decrease the future treatment burden as earlier detection moves patients into the treatment pool, though rising obesity may sustain high diabetes and hypertension numbers absent policy shifts.
- Medical inflation and the cost of treating chronic diseases are projected to increase at a slower rate than baseline for all conditions except heart disease, with overall medical costs remaining very close to but slightly above baseline projections when combining prevalence with cost per condition.
- Specific cost reductions are anticipated for stroke management through improved care and recurrence prevention, cancer treatment costs via earlier stage detection, and diabetes costs through better management and increased insulin pump utilization.
- Safeway's health care bill is currently on pace to reach $850 million by May, representing a $150 million reduction from projections, a model that the speaker suggests could cut national expenses in half if adopted by 30 companies or mandated by legislation.
- A proposal exists to test the Safeway model on 500,000 employees, with expectations that 85% participation would yield real data within one year, potentially stopping political arguments about health care spending through demonstrated health improvements and lower costs.
- Experts suggest that 40% cost reductions are achievable without legislative changes, but emphasize the need for urgent communication strategies, behavioral incentives such as tax credits or adjustments to Medicare payments, and innovative financing to integrate prevention functions into insurance structures.
- Preventive measures including daily exercise commitments of 30 to 45 minutes and muscle building through weightlifting are required to counter sedentary lifestyle effects, reduce the need for joint replacements and back pain treatments, and address the "thin on the outside, fat on the inside" phenotype.
- Medicare spending on chronic conditions is expected to remain high unless the reform agenda shifts from budget discussions to health policy discussions that embed proven programs like the Diabetes Prevention Program and cover effective new weight loss drugs.
- Future delays of five to ten years in implementing federal changes are feared to leave Congress with limited tools to slow entitlement spending, such as slashing provider payment rates or shifting costs to seniors, due to current CBO scoring systems that penalize public prevention investments.
- The private sector is viewed as having necessary innovators, but large-scale federal changes to Medicare and Medicaid are deemed essential for countrywide impact, as known solutions remain orphaned without integrated financing streams.
- Without a shift in policy to address obesity correctly through a nutrition philosophy rather than a deficiency model, the economic burden of chronic diseases is expected to persist, with 30% of the population needing targeted interventions to reverse weight gain trends.